Log in

Start free trial
PAMA Unlocks Golden Age for Innovative Diagnostics

PAMA Unlocks Golden Age for Innovative Diagnostics

by | Jul 30, 2018 | Clinical Diagnostics Insider, Earnings-lir, Fee Schedules-lir, Fee Schedules-nir, Funding-lir, Funding-nir, Health care reform-lir, Health care reform-nir, Inside the Diagnostics Industry-dtet, Inside the Lab Industry-lir, Reimbursement-dtet, Reimbursement-lca, Reimbursement-lir, Reimbursement-nir, Top of the News-dtet

By Chance Scott  bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…


. . . read more

FDA Speeding Approval Process, Continued User Fees Needed

by | Jun 26, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet, Top of the News-dtet

From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) is plagued with chronic understaffing, scrutiny over the length of time for approvals, and an expanding workload, while also…


. . . read more

This content is for Paid Members only.
Register
Already a member? Log in here